Semax Reconstitution Calculator

Research Use

Calculate precise U-100 syringe units, concentration (mg/mL), and doses per vial for Semax research.

Clinical Precision Tool

Semax Dosage Calculator

U-100 Calibrated
Calculated Syringe Draw
3.0Units
➜ 0.030 mL volume
0 Units100 Units Max
Concentration
10.00 mg/mL
Tick Marks
3.0 ticks
OE
Written by OnePeptideShip Editorial Team
Reviewed by Dr. Aris Thorne, MD, Board Certified Endocrinology Advisor
Updated September 2026

Clinical Pharmacology & Mechanism of Action

Semax is a synthetic heptapeptide (a chain of seven amino acids) that was originally developed by the Russian Institute of Molecular Genetics. It is an analogue of a fragment of adrenocorticotropic hormone (ACTH 4-10) but lacks any hormonal activity.

Instead, it acts entirely as a profound neuroprotector and nootropic (cognitive enhancer).

Its primary mechanism of action revolves around the modulation of neurotransmitters and neurotrophic factors in the brain:

  • BDNF & NGF Upregulation: Semax drastically increases the expression of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF). These are the "fertilizers" of the brain, promoting neurogenesis, synaptic plasticity, and the survival of neurons .
  • Dopaminergic and Serotonergic Tone: It modulates dopamine and serotonin receptors, leading to significant improvements in mood, focus, and motivation without the jittery stimulation associated with amphetamines.
  • Neuroprotection: In Russia, it is a standard medical treatment for acute ischemic stroke and traumatic brain injury, as it protects neurons from hypoxic damage and oxidative stress.

Pharmacokinetics & Administration Routes

  • Half-life: Extremely short in the plasma (minutes), but the cascading neurotrophic effects (like BDNF elevation) last for 20 to 24 hours.
  • Administration: While this calculator provides math for Subcutaneous (SubQ) injection, Semax is famously administered intranasally (via nasal spray) because it crosses the blood-brain barrier very effectively through the olfactory nerve.

Standard Research Dosing Protocols

Because Semax is so potent neurologically, it is dosed in very small microgram (mcg) quantities.

  • Dosage (SubQ): 100mcg to 300mcg.
  • Dosage (Intranasal): 200mcg to 600mcg (requires a slightly higher dose due to lower bioavailability compared to injection).
  • Frequency: 1 to 2 times daily (typically morning and early afternoon to avoid insomnia).

Reconstitution Math & Syringe Guide

Semax vials are incredibly dense, often sold in 30mg or 60mg vials. Calculating a 300mcg dose from a 30mg vial is where almost all researchers make catastrophic errors.

Step-by-Step Reconstitution (30mg Vial)

  1. Swab the rubber stoppers of your 30mg Semax vial and Bacteriostatic Water.
  2. Using a sterile mixing syringe, draw exactly 3mL of Bacteriostatic Water. (Using less water makes the solution too concentrated to measure accurately).
  3. Inject the water slowly down the inside wall of the Semax vial.
  4. Swirl gently.

The Math for a Standard Dose (300mcg):

  • 30mg total in the vial = 30,000mcg.
  • You added 3mL of water.
  • Therefore, the concentration is 10,000mcg per 1mL.
  • You need a 300mcg dose. Divide the dose by the concentration: 300 ÷ 10,000 = 0.03mL.
  • 0.03mL = 3 units on a U-100 syringe.

(Yes, 3 units. It is an incredibly tiny amount of liquid).

Common Mistakes & Troubleshooting

  • Confusing mg with mcg: The most dangerous mistake is treating Semax like TB-500. A 30mg vial contains ONE HUNDRED 300mcg doses. If you draw 30 units (0.3mL) instead of 3 units, you just injected 3,000mcg of Semax. While not physically fatal, this massive overdose causes extreme overstimulation, headaches, brain fog, and severe anxiety.
  • Using Nasal Spray Math for Syringes: A standard nasal spray pump delivers 0.1mL per spray. If you put 30mg of Semax in 3mL of water, one spray (0.1mL) equals 1,000mcg. You cannot use nasal spray math for SubQ syringes.
  • Late Day Dosing: The massive elevation in BDNF and dopamine can make it impossible to sleep if administered after 4:00 PM.

Medical & Research Disclaimer

The information provided on this page, including all calculations, is for educational and laboratory research purposes only. It does not constitute medical advice. Peptides mentioned here are not approved for human consumption outside of FDA-approved clinical trials unless specified otherwise. Always consult a licensed healthcare provider before undertaking any new therapy.

Frequently Asked Questions

Add 3mL of BAC water to the 30mg vial. This creates a concentration of 10mg/mL (10,000mcg/mL). For a standard 300mcg dose: 300 ÷ 10,000 = 0.03mL = just 3 units on a U-100 syringe. This is an extremely small draw. To make it easier, add 6mL of water instead (making it 5,000mcg/mL), which makes a 300mcg dose = 6 units.

Regular Semax is enzymatically degraded relatively quickly in the body. Researchers have developed two enhanced versions: N-Acetyl Semax (with an added acetyl group on the N-terminus) - more stable, slightly more potent. N-Acetyl Semax Amidate (NASX) - has both the acetyl group AND an amide group added to the C-terminus. This double modification makes it the most stable, most potent, and most blood-brain-barrier-penetrating form of Semax available. Effective doses of NASX are roughly 3-5x lower than regular Semax.

Researchers and subjects consistently report: significantly improved working memory and cognitive processing speed (typically noticeable within 30-60 minutes of injection), enhanced focus and mental clarity without jitteriness or stimulant "edge," elevated mood and motivation (via dopaminergic upregulation), reduced anxiety in many subjects, and improved learning and memory consolidation (via BDNF-driven synaptic plasticity). Effects are most pronounced in the first 6-8 hours.

Both routes work. Intranasal delivery rapidly transports Semax along the olfactory nerve directly to the brain, producing a very fast onset (10-20 minutes) but with roughly 60-70% bioavailability vs. injection. SubQ injection has 100% bioavailability, a slightly slower onset (30-45 minutes), and is more precisely dosed. Research protocols use both; injection is preferred for critical precision and maximum bioavailability.

Yes, extensively. Semax is used clinically in Russia (approved) for treating acute ischemic stroke, traumatic brain injury, optic nerve disease, and cognitive decline. Its mechanism of dramatically upregulating BDNF and NGF provides profound neuroprotection - essentially instructing neurons to survive and repair after injury. In stroke research, it is administered in the acute phase to limit neuronal death in the ischemic penumbra.

Most research protocols run 2-4 weeks on, followed by a 2-week break. This prevents tachyphylaxis (tolerance build-up) to the dopaminergic effects, which can reduce the nootropic impact over time. Because Semax works by genuinely upregulating BDNF/NGF synthesis (rather than depleting a neurotransmitter like stimulants do), it has a much more favorable tolerance profile than amphetamine-class nootropics.

Semax is considered well-tolerated with a clean side effect profile. The most commonly reported issues are: mild headaches (especially in the first few days of use, from increased brain activity), mild anxiety or restlessness in subjects sensitive to dopaminergic activation, insomnia if taken too late in the day, and a mild "crash" or flat mood the day after stopping an extended cycle (due to BDNF normalization).

Related Research Calculators